112 related articles for article (PubMed ID: 2885450)
21. The effect of hemodilution upon patients with intermittent claudication.
Wolfe JH; Waller DG; Chapman MB; Blackford HN; Prout WG
Surg Gynecol Obstet; 1985 Apr; 160(4):347-51. PubMed ID: 2580361
[TBL] [Abstract][Full Text] [Related]
22. The effect of pain-free treadmill training on fibrinogen, haematocrit, and lipid profile in patients with claudication.
Mika P; Wilk B; Mika A; Marchewka A; Nizankowski R
Eur J Cardiovasc Prev Rehabil; 2011 Oct; 18(5):754-60. PubMed ID: 21450630
[TBL] [Abstract][Full Text] [Related]
23. The effectiveness of isoxsuprine in patients with intermittent claudication.
Skotnicki SH; van Gaal G; Wijn PF
Angiology; 1984 Nov; 35(11):685-93. PubMed ID: 6388424
[TBL] [Abstract][Full Text] [Related]
24. The efficacy of transcutaneous electrical nerve stimulation on the improvement of walking distance in patients with peripheral arterial disease with intermittent claudication: study protocol for a randomised controlled trial: the TENS-PAD study.
Besnier F; Sénard JM; Grémeaux V; Riédel M; Garrigues D; Guiraud T; Labrunée M
Trials; 2017 Aug; 18(1):373. PubMed ID: 28797281
[TBL] [Abstract][Full Text] [Related]
25. [Isovolemic hemodilution in stage-IIb peripheral arterial occlusive diseases. Prospective randomized double-blind comparison of middle-molecule hydroxyethyl starch and electrolyte solution].
Kiesewetter H; Jung F; Blume J; Gerhards M
Dtsch Med Wochenschr; 1986 Aug; 111(35):1307-12. PubMed ID: 2427301
[TBL] [Abstract][Full Text] [Related]
26. Blood viscosity during long-term treatment with ticlopidine in patients with intermittent claudication. A double-blind study.
Fagher B; Persson S; Persson G; Larsson H
Angiology; 1993 Apr; 44(4):300-6. PubMed ID: 8457081
[TBL] [Abstract][Full Text] [Related]
27. Haemodilution in patients with peripheral arterial occlusive disease.
Kiesewetter H; Jung F; Erdlenbruch W; Wenzel E
Int Angiol; 1992; 11(3):169-75. PubMed ID: 1281205
[TBL] [Abstract][Full Text] [Related]
28. A feasibility double-blind randomized placebo-controlled trial of extracorporeal shockwave therapy as a novel treatment for intermittent claudication.
Harwood AE; Green J; Cayton T; Raza A; Wallace T; Carradice D; Chetter IC; Smith GE
J Vasc Surg; 2018 Feb; 67(2):514-521.e2. PubMed ID: 28943002
[TBL] [Abstract][Full Text] [Related]
29. Effects of chronic isovolaemic haemodilution on regional cerebral blood flow in conscious rats.
Frietsch T; Lenz C; Kuschinsky W; Waschke KE
Eur J Anaesthesiol; 2004 Jan; 21(1):53-9. PubMed ID: 14768924
[TBL] [Abstract][Full Text] [Related]
30. Regarding "an analysis of relationship between quality of life indices and clinical improvement following intervention in patients with intermittent claudication due to femoropopliteal disease".
Frans FA; Koelemay MJ
J Vasc Surg; 2011 Apr; 53(4):1164; author reply 1164. PubMed ID: 21439465
[No Abstract] [Full Text] [Related]
31. Effects of ethaverine hydrochloride on the walking tolerance of patients with intermittent claudication.
Trainor FS; Phillips RE; Michie DD; Zellner SR; Hogan L; Chubb JM
Angiology; 1986 May; 37(5):343-51. PubMed ID: 3521401
[TBL] [Abstract][Full Text] [Related]
32. Placebo-controlled trial of ketanserin in the treatment of intermittent claudication.
Cameron HA; Waller PC; Ramsay LE
Angiology; 1987 Jul; 38(7):549-55. PubMed ID: 3304029
[TBL] [Abstract][Full Text] [Related]
33. Magnetic resonance imaging-based monitoring of collateral artery development in patients with intermittent claudication during supervised exercise therapy.
Versluis B; Leiner T; Nelemans PJ; Wildberger JE; Schurink GW; Backes WH
J Vasc Surg; 2013 Nov; 58(5):1236-43. PubMed ID: 23522901
[TBL] [Abstract][Full Text] [Related]
34. Blood rheology changes during bezafibrate treatment.
Caimi G; Francavilla G; Romano A; Catania A; Santonocito G; Sarno A
Br J Clin Pract; 1988 Nov; 42(11):456-8. PubMed ID: 3076782
[TBL] [Abstract][Full Text] [Related]
35. Effects of naftidrofuryl in patients with intermittent claudication.
Karnik R; Valentin A; Stöllberger C; Slany J
Angiology; 1988 Mar; 39(3 Pt 1):234-40. PubMed ID: 3281516
[TBL] [Abstract][Full Text] [Related]
36. Ticlopidine in the treatment of intermittent claudication: a 21-month double-blind trial.
Balsano F; Coccheri S; Libretti A; Nenci GG; Catalano M; Fortunato G; Grasselli S; Violi F; Hellemans H; Vanhove P
J Lab Clin Med; 1989 Jul; 114(1):84-91. PubMed ID: 2661700
[TBL] [Abstract][Full Text] [Related]
37. [Placebo-controlled double-blind study of the effectiveness of Ginkgo biloba special extract EGb 761 in trained patients with intermittent claudication].
Blume J; Kieser M; Hölscher U
Vasa; 1996; 25(3):265-74. PubMed ID: 8967154
[TBL] [Abstract][Full Text] [Related]
38. The impact of sex on angioplasty and primary stenting for femoropopliteal occlusive disease: results of the DURABILITY II trial.
Tadros RO; Faries PL; Rocha-Singh KJ; Kim Sy; Malik RK; Ellozy SH; Marin ML; Vouyouka AG
Ann Vasc Surg; 2014 Jan; 28(1):1-9. PubMed ID: 24189009
[TBL] [Abstract][Full Text] [Related]
39. Placebo-controlled double-blind trial of ketanserin in treatment of intermittent claudication.
De Cree J; Leempoels J; Geukens H; Verhaegen H
Lancet; 1984 Oct; 2(8406):775-9. PubMed ID: 6148522
[TBL] [Abstract][Full Text] [Related]
40. Haemorheological changes in patients with retinal vein occlusion after isovolaemic haemodilution.
Wiek J; Schade M; Wiederholt M; Arntz HR; Hansen LL
Br J Ophthalmol; 1990 Nov; 74(11):665-9. PubMed ID: 2223704
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
